Efficient ROSA26-based conditional and/or inducible transgenesis using RMCE-compatible F1 hybrid mouse embryonic stem cells

Stem Cell Reviews and Reports

Volumn 9, Issue 6, 2013, Pages 774-785

  Haenebalcke, Lieven ^a,b   Goossens, Steven ^a,b   Naessens, Michael ^a,b   Kruse, Natascha ^c   Ghahremani, Morvarid Farhang ^a,b   Bartunkova, Sonia ^a,b   Haigh, Jody J ^a,b,d   Pieters, Tim ^a,b   Dierickx, Pieterjan ^a,b   Drogat, Benjamin ^a,b   Nyabi, Omar ^a,b   Wirth, Dagmar ^c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Conditional Inducible (COIN); Gateway technology; Insulators; Mouse embryonic stem cells; Recombinase mediated cassette exchange (RMCE); ROSA26

Indexed keywords

GT(ROSA)26SOR NON CODING RNA, MOUSE; GT(ROSA)26SOR NON-CODING RNA, MOUSE; RECOMBINASE; UNTRANSLATED RNA;

ANIMAL; ARTICLE; CROSS BREEDING; CYTOLOGY; EMBRYONIC STEM CELL; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE TRANSFER; HYBRIDIZATION; MALE; METABOLISM; MOUSE;

ANIMALS; CROSSES, GENETIC; EMBRYONIC STEM CELLS; FEMALE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC LOCI; HYBRIDIZATION, GENETIC; MALE; MICE; RECOMBINASES; RNA, UNTRANSLATED;

EID: 84903671521     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-013-9458-z     Document Type: Article

References (43)

1. Wirth, D., Gama-Norton, L., Riemer, P., Sandhu, U., Schucht, R., & Hauser, H. (2007). Road to precision: recombinase-based targeting technologies for genome engineering. Current Opinion in Biotechnology, 18, 411-419.
2. Yamamoto, A., Hen, R., & Dauer, W. T. (2001). The ons and offs of inducible transgenic technology: a review. Neurobiology of Disease, 8, 923-932.
3. Beard, C., Hochedlinger, K., Plath, K., Wutz, A., & Jaenisch, R. (2006). Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis, 44, 23-28.
4. Maes, C., Goossens, S., Bartunkova, S., et al. (2010). Increased skeletal VEGF enhances beta-catenin activity and results in excessively ossified bones. EMBO Journal, 29, 424-441.
5. Belteki, G., Haigh, J., Kabacs, N., et al. (2005). Conditional and inducible transgene expression in mice through the combinatorial use of Cre-mediated recombination and tetracycline induction. Nucleic Acids Research, 33, e51.
6. Mao, J., Barrow, J., McMahon, J., Vaughan, J., & McMahon, A. P. (2005). An ES cell system for rapid, spatial and temporal analysis of gene function in vitro and in vivo. Nucleic Acids Research, 33, e155.
7. Yu, H. M., Liu, B., Chiu, S. Y., Costantini, F., & Hsu, W. (2005). Development of a unique system for spatiotemporal and lineagespecific gene expression in mice. Proceedings of the National Academy of Sciences of the United States of America, 102, 8615-8620.
8. Nyabi, O., Naessens, M., Haigh, K., et al. (2009). Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cells. Nucleic Acids Research, 37, e55.
9. Hitz, C., Wurst, W., & Kuhn, R. (2007). Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference. Nucleic Acids Research, 35, e90.
10. Medina, P. P., Nolde, M., & Slack, F. J. (2010). OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature, 467, 86-90.
11. Soriano, P. (1999). Generalized lacZ expression with the ROSA26 Cre reporter strain. Nature Genetics, 21, 70-71.
12. Katzen, F. (2007). Gateway(R) recombinational cloning: a biological operating system. Expert Opinion Drug Discovery, 2, 571-589.
13. Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
14. Haenebalcke, L., Goossens, S., Dierickx, P., et al. (2013). The ROSA26-iPSC mouse: a conditional, inducible, and exchangeable resource for studying cellular (De)Differentiation. Cell Rep, 3, 335-341.
15. Sandhu, U., Cebula, M., Behme, S., et al. (2011). Strict control of transgene expression in a mouse model for sensitive biological applications based on RMCE compatible ES cells. Nucleic Acids Research, 39, e1.
16. Seibler, J., Kleinridders, A., Kuter-Luks, B., Niehaves, S., Bruning, J. C., & Schwenk, F. (2007). Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic Acids Research, 35, e54.
17. Schebelle, L., Wolf, C., Stribl, C., et al. (2010). Efficient conditional and promoter-specific in vivo expression of cDNAs of choice by taking advantage of recombinase-mediated cassette exchange using FlEx gene traps. Nucleic Acids Research, 38, e106.
18. Strathdee, D., Ibbotson, H., & Grant, S. G. (2006). Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent. PLoS One, 1, e4.
19. Oyer, J. A., Chu, A., Brar, S., & Turker, M. S. (2009). Aberrant epigenetic silencing is triggered by a transient reduction in gene expression. PLoS One, 4, e4832.
20. Chen, C. M., Krohn, J., Bhattacharya, S., & Davies, B. (2011). A comparison of exogenous promoter activity at the ROSA26 locus using a PhiC31 integrase mediated cassette exchange approach in mouse ES cells. PLoS One, 6, e23376.
21. Chung, S., Andersson, T., Sonntag, K. C., Bjorklund, L., Isacson, O., & Kim, K. S. (2002). Analysis of different promoter systems for efficient transgene expression in mouse embryonic stem cell lines. Stem Cells, 20, 139-145. Dayton, Ohio.
22. Bagchi, B., Kumar, M., & Mani, S. (2006). CMV promotor activity during ES cell differentiation: potential insight into embryonic stem cell differentiation. Cell Biology International, 30, 505-513.
23. Wang, R., Liang, J., Jiang, H., Qin, L. J., & Yang, H. T. (2008). Promoter-dependent EGFP expression during embryonic stem cell propagation and differentiation. Stem Cells and Development, 17, 279-289.
24. Tchorz, J. S., Suply, T., Ksiazek, I., et al. (2012). A modified RMCE-compatible Rosa26 locus for the expression of transgenes from exogenous promoters. PLoS One, 7, e30011.
25. Zhu, P., Aller, M. I., Baron, U., et al. (2007). Silencing and unsilencing of tetracycline-controlled genes in neurons. PLoS One, 2, e533.
26. Mehta, A. K., Majumdar, S. S., Alam, P., Gulati, N., & Brahmachari, V. (2009). Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice. Gene, 428, 20-24.
27. Pikaart, M. J., Recillas-Targa, F., & Felsenfeld, G. (1998). Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes & Development, 12, 2852-2862.
28. Wang, Y., DeMayo, F. J., Tsai, S. Y., & O'Malley, B. W. (1997). Ligand-inducible and liver-specific target gene expression in transgenic mice. Nature Biotechnology, 15, 239-243.
29. Ciavatta, D., Kalantry, S., Magnuson, T., & Smithies, O. (2006). A DNA insulator prevents repression of a targeted X-linked transgene but not its random or imprinted X inactivation. Proceedings of the National Academy of Sciences of the United States of America, 103, 9958-9963.
30. Hasegawa, K., & Nakatsuji, N. (2002). Insulators prevent transcriptional interference between two promoters in a double gene construct for transgenesis. FEBS Letters, 520, 47-52.
31. George, S. H., Gertsenstein, M., Vintersten, K., et al. (2007). Developmental and adult phenotyping directly from mutant embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 104, 4455-4460.
32. Novak, A., Guo, C., Yang, W., Nagy, A., & Lobe, C. G. (2000). Z/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision. Genesis, 28, 147-155.
33. Schlake, T., & Bode, J. (1994). Use of mutated FLP recognition target (FRT) sites for the exchange of expression cassettes at defined chromosomal loci. Biochemistry, 33, 12746-12751.
34. Sekkali, B., Tran, H. T., Crabbe, E., De Beule, C., Van Roy, F., & Vleminckx, K. (2008). Chicken beta-globin insulator overcomes variegation of transgenes in Xenopus embryos. The FASEB Journal, 22, 2534-2540.
35. Bondue, A., & Blanpain, C. (2010). Mesp1: a key regulator of cardiovascular lineage commitment. Circulation Research, 107, 1414-1427.
36. Nehlsen, K., Schucht, R., da Gama-Norton, L., et al. (2009). Recombinant protein expression by targeting pre-selected chromosomal loci. BMC Biotechnology, 9, 100.
37. Schucht, R., Coroadinha, A. S., Zanta-Boussif, M. A., et al. (2006). A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Molecular Therapy, 14, 285-292.
38. Pieters, T., Haenebalcke, L., Hochepied, T., et al. (2012). Efficient and user-friendly pluripotin-based derivation of mouse embryonic stem cells. Stem Cell Reviews, 8, 768-778.
39. Taboit-Dameron, F., Malassagne, B., Viglietta, C., et al. (1999). Association of the 5′HS4 sequence of the chicken beta-globin locus control region with human EF1 alpha gene promoter induces ubiquitous and high expression of human CD55 and CD59 cDNAs in transgenic rabbits. Transgenic Research, 8, 223-235.
40. Premsrirut, P. K., Dow, L. E., Kim, S. Y., et al. (2011). A rapid and scalable system for studying gene function in mice using conditional RNA interference. Cell, 145, 145-158.
41. Sharma, S. V., & Settleman, J. (2007). Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes & Development, 21, 3214-3231.
42. Weinstein, I. B., & Joe, A. (2008). Oncogene addiction. Cancer Research, 68, 3077-3080. discussion 3080.
43. Kelkar, M., & De, A. (2012). Bioluminescence based in vivo screening technologies. Current Opinion in Pharmacology, 12, 592-600.